Immunotherapy may be preferable to chemotherapy for patients with POD24 follicular lymphoma in the second‐line setting

British Journal of Haematology 2026

View at publisher
Authors: Serna Alcántara Miguel Ángel, Bosch Marc, Navarro Víctor, López‐Pereira Patricia, David Quintela, Sancho Juan‐Manuel, Sáez Adolfo, Jiménez‐Ubieto Ana, Juan Carlos Caballero, Córdoba Raúl, Cerdà María, Beatriz De La Cruz
+18 more Romero Samuel, Ainara Ferrero, Tomás Garcia, Villalobos Teresa, Rivero Andrea, Vázquez Sofía, Villafuerte Paola, Herrero Carmen, Miguel Ángel Canales, Miguel Alcoceba, Alejandro Martín García‐Sancho, Marco Javier, García Cristina, Marín‐Niebla Ana, Gloria Iacoboni, Bosch Francesc, Abrisqueta Pau, the GELTAMO group (Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea)
DOI: 10.1111/bjh.70298
Cited by: 1
References: 14

Abstract

The data that support the findings of this study are available from the corresponding author upon reasonable request. Data S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment Cutaneous lymphoproliferative disorders research CNS Lymphoma Diagnosis and Treatment

Publication details

Journal / source
British Journal of Haematology
Publisher
Wiley
Volume
208
Issue
3
Pages
1105–1110
Publication date
20 January 2026
Language
EN